|
|
EQSNews: AATec Medical GmbH
/ Key words: Personnel
AATec Medical appoints Professor Dr. Claus Franz Vogelmeier to the Scientific Advisory Board
29.02.2024 / 09:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
AATec Medical appoints Professor Dr. Claus Franz Vogelme... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: AATec Medical GmbH
/ Key words: Alliance
AATec Medical starts collaboration with the German Federal Agency for Disruptive Innovation SPRIND for alpha1 antitrypsin
06.02.2024 / 09:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
AATec Medical starts collab... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: AATec Medical GmbH
/ Key words: Alliance
AATec Medical and Beurer enter development collaboration for inhaled Alpha1 Antitrypsin
31.10.2023 / 10:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
AATec Medical and Beurer enter development collaboration for... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: AATec Medical GmbH
/ Key words: Miscellaneous
AATec Medical GmbH: AATec Medical Announces Creation of Scientific Advisory Board
10.10.2023 / 11:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
AATec Medical Announces Creation of Scientif... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: AATec Medical GmbH
/ Key words: Financing
AATec Medical GmbH: AATec Medical Announces its Launch with EUR 2.7 million in Seed Financing to Unlock the Therapeutic Potential of Alpha1 Antitrypsin
17.07.2023 / 11:00 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
